American Thoracic Society: Survey Reveals Majority of Patients Diagnosed With Chronic Pulmonary Disorders Are Unaware of Standard-of-Care Treatment for Their Deadly Disease
Sixty-two percent of people diagnosed with chronic pulmonary disorders have never heard of pulmonary rehabilitation - an effective non-pharmacological treatment option covered by Medicare and private insurance - according to a survey released today by the
Pulmonary rehabilitation is a comprehensive 6- to 12-week program of exercise and education that is proven to reduce symptoms, improve exercise capacity and enhance quality of life for patients living with chronic respiratory diseases. However, it is significantly underutilized, particularly as compared to pharmacological treatments such as inhalers or steroids. A recent study published in the Annals of the
The survey sample comprised 500 patients1 diagnosed with COPD, pulmonary hypertension, interstitial lung disease or other chronic pulmonary disorders. It was conducted by
Chronic respiratory diseases, the most common being chronic obstructive pulmonary disease (COPD), are the third leading cause of death in the
The new survey data builds upon the 2015
People with chronic respiratory diseases are often limited in many daily activities and may not be able to even walk from one side of their home to the other, prepare a meal or wash their hair, according to
"With these diseases being a leading cause of death and the only one that's on the rise, we had to ask, 'Why aren't patients getting treatment that's proven to reduce their symptoms and improve their quality of life?'" said Rochester. "Although the ATS/ERS statement addressed this issue, this is the first
According to the new survey, in contrast with the lack of knowledge of pulmonary rehabilitation, the majority of patients with a chronic pulmonary disorder have heard of oxygen therapy (70 percent) as well as medicinal interventions, including long-acting or maintenance inhalers (61 percent), short-acting or rescue inhalers (52 percent) and inhaled or oral steroids (52 percent) as treatments for their disease.
The Wakefield survey also found that many patients who have heard of pulmonary rehabilitation do not pursue treatment or fail to complete treatment. Of the 38 percent of respondents who had heard of pulmonary rehabilitation, only 29 percent completed the program. For those who did not participate in pulmonary rehabilitation or started and did not complete the program, the following were the most common reasons given:
* 36 percent said it is too difficult to travel there.
* 28 percent said the program is too expensive.
* 27 percent said their breathing is so bad, it is difficult to leave home.
* 27 percent said it is emotionally too difficult, such as due to feelings of embarrassment or anxiety.
"Understanding the reasons why people don't utilize pulmonary rehab and minimizing the barriers to participation enables us to help more people with COPD and other chronic respiratory diseases get the treatment they need," said
The survey revealed that more than half (57 percent) of respondents avoid climbing stairs due to their breathing problems. Half (50 percent) don't carry items when they walk. Other avoided tasks include:
* Household chores, such as cleaning the house or doing laundry (48 percent)
* Going outside their home to do errands, such as grocery shopping (43 percent)
* Going outside their home to attend social events or gatherings (42 percent)
* Caring for their pet(s), such as taking them for walks (37 percent)
* Playing with or entertaining their children or grandchildren (37 percent)
* Cooking or preparing meals (28 percent)
* Daily personal hygiene tasks, such as washing their hair or brushing their teeth (28 percent)
People who complete a pulmonary rehabilitation program report having a positive experience.
"When I first started pulmonary rehabilitation, I couldn't even get mail from my mailbox, so it was hard to imagine exercising. Every two weeks, I added in a new activity and within nine months, I was able to do most of what I wanted to do," said
Health iPASS Raises $10 Million Series A Funding on its Quest to Guarantee Patient Payments
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News